课题基金 / 基金详情

Myeloid Suppressor Cells in Sepsis and Trauma

Myeloid Suppressor Cells in Sepsis and Trauma
败血症和创伤中的骨髓抑制细胞
批准号:
7617966
负责人:
LYLE L MOLDAWER
金额:
$26.37万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-05-01 至 2012-02-28
关键词:
AddressAdoptive TransferAgonistAnimalsAntibodiesAntibody FormationAntigensAreaAttentionBacterial InfectionsBiologicalBiological AssayBloodBone MarrowBurn injuryCD34 geneCD4 Positive T LymphocytesCD8B1 geneCSF1R geneCSF3 geneCell CountCell physiologyCell surfaceCellsChimera organismClinical TrialsCoculture TechniquesCommunitiesDataDefectDendritic CellsDevelopmentDiseaseEnvironmentExhibitsFlow CytometryGoalsGranulocyte-Macrophage Colony-Stimulating FactorGrowth FactorHarvestHelper-Inducer T-LymphocyteHematopoieticHistologyHomeostasisITGAM geneImmature MonocyteImmuneImmune responseImmunityImmunoglobulinsImmunosuppressionImmunosuppressive AgentsIn VitroInfectionInflammatoryInflammatory ResponseInterferonsInterleukin-10Interleukin-4InterventionIntravenousKnockout MiceLaboratoriesLeadLifeLigationListeriaListeriosisLiteratureLymphoidMalignant NeoplasmsMeasuresMediatingMediator of activation proteinModelingMusMyelogenousMyeloid CellsNomenclatureOpportunistic InfectionsOrganOutcomePECAM1 genePatientsPhenotypePlayPneumoniaPopulationPopulation HeterogeneityPredispositionProcessProductionPropertyProteinsPseudomonasPseudomonas InfectionsPseudomonas aeruginosaPublishingPuncture procedureReactive Oxygen SpeciesRecombinantsReportingResearchRiskRoleSepsisSepsis SyndromeShockSignal PathwaySignal TransductionSorting - Cell MovementSpleenSplenocyteStagingStressSuppressor-Effector T-LymphocytesT-Cell ProliferationT-Cell ReceptorT-LymphocyteTLR4 geneTestingTherapeutic InterventionTimeTraumaTretinoinTumor-Derivedacquired immunityc-fms Proto-Oncogenescell typecytokinedepresseddepressionfree radical oxygengranulocyteimprovedin vivoinhibitor/antagonistinnovationkinase inhibitorknockout animallymph nodesmacrophagemembermicrobialnovelnovel therapeutic interventionnovel therapeuticspopulation basedpreventprogenitorprogramsreceptorreconstitutionresponsesecondary infectionseptictherapeutic targettranslational studytumor

项目摘要

项目成果

LYLE L MOLDAWER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Sepsis is associated with aberrations in adaptive immunity that place the host at increased risk of secondary opportunistic infections. The overall goal of this proposal is to determine whether myeloid-derived suppressor cell populations (MDSC) contribute to outcome and the adaptive immune suppression seen in severe sepsis. MDSCs are a heterogeneous population of immature myeloid cells with suppressor cell activities. Understanding how these regulatory cells act during sepsis may permit the development of potential novel therapeutic avenues to ameliorate the immune suppression observed in severe sepsis. Therefore, three specific aims are proposed: 1. To determine which MDSC cell subpopulations possess these immunosuppressive properties, and through what mechanism(s) (NO, reactive oxygen species) are these immunosuppressive properties obtained. 2. To confirm and identify the MyD88 dependent cell processes that are required for the expansion of the MDSC populations in microbial sepsis, and whether these MyD88 dependent processes involve endogenous production of members of the CSF superfamily, and 3. To determine whether alterations in the MDSC population in response to sepsis modulates the acquired immune response, and can alter outcome to a secondary infectious challenge. Both MDSC numbers and function will be quantitated in septic mice, as will the degree of adaptive immunosuppression and susceptibility to a secondary bacterial challenge. MdSC numbers (CD31+CD11b+GR-1+) will be determined by flow cytometry, while suppressor cell activity will be evaluated functionally by co-culture with CD4+ and CD8+ splenocytes in response to antigen specific and nonspecific proliferative signals. Under in vivo conditions, the effect of these MDSC populations on T helper cell polarization (Th1 vs Th2) will also be determined. Finally, mice at the above time points post-CLP will be subjected to a secondary bacterial infection (Pseudomonas aeruginosa pneumonia, or Listeriosis) to determine their susceptibility. Thus, the proposed studies represent an innovative examination of a novel suppressor cell population as a potential mechanism for immune suppression during sepsis. PUBLIC HEALTH RELEVANCE: Sepsis is a life-threatening disease associated with significant immune suppression. Understanding the role that immature myeloid derived suppressor cells play in sepsis could lead to new therapeutic interventions. This program will explore the mechanisms responsible for the massive expansion of this cell population in the bone marrow, spleen and lymph nodes in sepsis, and the mechanisms behind its contribution to sepsis induced immune suppression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Stratifying Patient Immune Endotypes in Sepsis (SPIES Study)
  • 批准号:
    10439853
  • 项目类别:
  • 资助金额:
    $74.89万
  • 财政年份:
    2020
  • 负责人:
    LYLE L MOLDAWER
  • 依托单位:
Stratifying Patient Immune Endotypes in Sepsis (SPIES Study)
  • 批准号:
    10651650
  • 项目类别:
  • 资助金额:
    $73.48万
  • 财政年份:
    2020
  • 负责人:
    LYLE L MOLDAWER
  • 依托单位:
Stratifying Patient Immune Endotypes in Sepsis (SPIES Study)
  • 批准号:
    10042541
  • 项目类别:
  • 资助金额:
    $80.15万
  • 财政年份:
    2020
  • 负责人:
    LYLE L MOLDAWER
  • 依托单位:
Stratifying Patient Immune Endotypes in Sepsis (SPIES Study)
  • 批准号:
    10254395
  • 项目类别:
  • 资助金额:
    $76.16万
  • 财政年份:
    2020
  • 负责人:
    LYLE L MOLDAWER
  • 依托单位:
海外基金